Healthcare Blogs

  Market Synopsis: Market Research Future (MRFR)’s latest study reveals that the global bone graft substitutes market is expected to expand at 6.52% CAGR during the forecast period 2017 to 2027. The market is set to reach a valuation of USD 5,031 Mn by the end of the assessment period. The increasing prevalence of diseases related to bones has intensified the demand for bone graft substitutes. Additionally, the rising awareness about the developments in bone graft substitutes coupled with rising healthcare expenditure is likely to augment the market size and revenue over the next couple of years. The painful procedure related to autografts have paved the way for developments in the bone graft substitutes market. Hence, the demand for alternatives such as allografts, xenografts, and synthetic bone grafts has been on the rise. It is projected to aid the proliferation of the market in the forthcoming years by accelerating its adoption. The growth of the  bone graft substitutes marke t is

  Human Insulin Market – Overview Human insulin is also known as synthetic insulin which is prepared in laboratory and has same characteristics like natural insulin. Human insulin was developed through the 1960s and 1970s and approved for pharmaceutical use in 1982. Before the invention of human insulin animal insulin, usually a purified form of porcine was used. According to a recent study report published by the Market Research Future, the global market for  Human Insulin Market  is expected to reach up to $40 billion by the end of the forecasted period and is expected to grow at a CAGR of ~10-12% during the forecast period (2016-2021). Today, approximately 100 million people around the world need insulin, including all people living with type 1 diabetes and between 10-25 percent of people with type 2 diabetes. Although  recombinant human insulin  has been used in the treatment of diabetes for over 90 years, globally more than half of those who need insulin today still cannot afford

  Market Highlights Lung cancer is a malignant lung tumor characterized by uncontrolled cell growth in lung tissue with symptoms such as coughing, weight loss, fatigue and chest pain. The two types of lung cancers are small-cell lung carcinoma (SCLC) and non-small-cell lung carcinoma (NSCLC). The NSCLC type accounts for almost 80% of the cancers with NSCLC representing the remaining. The cure rates for the two types of lung cancers exchange their positions with the SCLC being the most malignant. The cure rates also depend on the stage of cancer detection with rates varying by 55% for first stage to just 1% for stage four. Almost 85% of cases of  Lung Cancer Therapeutics market  are due to long-term tobacco smoking. Cigarette smoke contains at least 73 known carcinogens. Other factors causing lung cancer are genetic factors and exposure to triggers and carcinogens such as radon gas, asbestos, radioactive materials, second-hand smoke, or air pollution. It has also been demonstrated that

  Overview   The global aesthetics market, during the forecast period 2019 to 2025, will register growth at a CAGR of 10.08%. The market for aesthetics is set to reach USD 12,175.1 million by 2025. As per analysts, the global market is anticipated to witness growth owing to the factors such as noninvasive and minimally invasive aesthetic procedures as well as the demand for noninvasive and minimally invasive aesthetic procedures. However, the aesthetics market will face challenges and restraints due to risks associated with aesthetic procedures and the growing demand for advanced devices during the forecast period 2019 to 2025. Emergence of technically innovative devices in the market is set to play a key role in determining the growth potential during 2019 to 2025 years. Analysts have also studied the aesthetics market to understand potential threats and challenges the market companies could face. Although the  aesthetics market  is poised to grow at a fast pace across procedure and e

  Ambulatory Services Market Overview Ambulatory service or ambulatory care is a broad term used to describe medical care performed at the OPDs or on an outpatient basis, without admission to a hospital or other facility.  Ambulatory Care Services Centers only treat patients with chronic or non-severe acute conditions providing dialysis clinics,  capital region ambulatory surgery center , hospital outpatient departments, and others. Many medical procedures and surgeries once provided in hospitals have shifted to ambulatory services thanks to technology advancements. Ambulatory services executives coordinate all aspects of outpatient care instead of Doctors and Nurses, making sure the ASC has the strong clinical, financial, and operational footing needed to deliver top-notch patient services. Besides, rapidly undergoing through transformations, advancements in genetics, biomedical, and information technology; Healthcare sector is ushering towards effective personalized treatments for th

  Market Highlights Gallstones are deposits of cholesterol and other digestive fluids that form in the gallbladder. Cholic acid is used as an active pharmaceutical ingredient in manufacturing medications for dissolution of gallstones. Apart from treating gallstones, cholic acid is also used in treating bile acid synthesis disorders and Zellweger Spectrum Disorders. The  Global  Cholic Acid Market  is expected to register a  CAGR of   7.90%  during the forecast period with a market value of  USD 92,412.51 Thousand till 2024.  High prevalence of gallbladder cancer, high prevalence of obesity, and increasing geriatric population is anticipated to drive the market growth. However, stringent regulatory policies are likely to hamper the market growth. Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/8091 Regional Analysis The global cholic acid market, based on region, is divided into Europe, Asia-Pacific, Americas, and the Middle East & Africa. Asia-Pacif

  Market Highlights The  CBD Oil Market  is estimated to be valued at  USD 3782.32 Million by 2024  and expected to grow at a  CAGR of 38.45%  during the forecast period .  CBD is a cannabinoid found in the cannabis plant. CBD oil acts as a natural pain reliever, have anti-inflammatory properties and could reduce epileptic seizures, etc. From the past few years, the market for CBD oil had been increasing owing to rising legalization of cannabis and growing R&D in the field. Following the same, it is noted that new market players have been emerging in the market owing to the rising demand for CBD oil. Segment Analysis Global  CBD oil market  has been segmented on the basis of type, and application. On the basis of type, the market has been divided into hemp-derived and marijuana-derived types. The Hemp-derived CBD oil type is holding the major share of the overall CBD oil market. It has been estimated that the hemp-derived segment is growing at the highest CAGR to reach  USD 2,092.9

  Market Highlights Mixed Reality (MR) is a combination of Augmented Reality (AR) and Virtual Reality (VR), defining the polar ends of a spectrum known as virtuality spectrum or mixed reality spectrum. Augmented reality delivers digital components, whereas virtual reality enables immersive imitation of real-life settings. MR has widespread applications in different fields of healthcare, varying from treatment to training and education. It is estimated that the global mixed reality in healthcare market is expected to register a CAGR 26.3% during the forecast period of 2019 to 2024, with an estimated market value of USD 2,475 million in 2024. Numerous factors such as rapid improvements in the adoption of sensor technology, increase in the user acceptance, increased applications of MR in disease care and treatment, and increasing workload of healthcare professionals are anticipated to fuel the growth of the market. Additionally, the benefits of MR systems such as operational efficiency, i

  Market Insights Market Research Future has revealed that the global autoinjectors market is expected to witness exponential growth at a CAGR of over 25% during the forecast period of 2018 to 2023. Autoinjectors are an advancement in healthcare which dispenses a single dose of the given drug in an easy, and safe manner. Autoinjectors are commonly known for their use in epinephrine pen which is used to offer emergency care to patients suffering from anaphylactic shock. Other applications for autoinjectors in healthcare in addition to the above are expected to spur growth for the global autoinjector market. Increasing prevalence of targeted therapies for the treatment of various conditions is expected to increase market value. The growing diagnosis of diseases such as diabetes and a general increase in anaphylaxis have increased the demand for autoinjectors. Moreover, design development to increase efficiency and safety with which medicine is delivered combined with technological advanc

  Market Highlights Stethoscope Market is expected to register a CAGR 5.2% with an estimated market value of USD 520.0 million during the forecast period of 2021 to 2028. The global  stethoscope market  is currently dominated by many market players. The key players in the market are involved in new product launches and strategic partnerships to strengthen its market position. For instance, in January 2018, M3DICINE Inc, announced the launch of Stethee, the world’s first AI-enabled stethoscope system. Also, in September 2015, eKuore launched the first wireless stethoscope in Düsseldorf, Germany. Numerous factors such as increasing incidence rate of life-threatening diseases, increased spending on healthcare, and continuous research and development in the diagnostic field are anticipated to fuel the growth of the market. The technological improvements such as Bluetooth connectivity with digital wireless hearing aids is expected to fuel the market growth. Also, increasing research activit

  Market Highlights It is estimated that the global medical telemetry market is expected to register a CAGR ~21% during the forecast period of 2019 to 2024.  The global  medical telemetry market  is expected to witness tremendous growth owing to the information and communication technology or ICT, advancement in mobile perforation, and connectivity in the region is driving the growth of the medical telemetry market. Other factors such as the advent of various new-age facilities such as mHealth, virtual visits, and tele-ICUs. The industry players such as InTouch Health, iRobot, and Vecna Technologies have developed robots that serve as the physician's stand-in in remote clinics, which are the key factor driving the growth of the segment. However, factors such as low awareness about telemetry in the emerging region are expected to curb the growth of the market during the forecast period. Segmentation The global medical telemetry market is segmented on the basis of component, service,

  Market Highlights Cardiology picture archiving and communication systems (CPACS) and cardiovascular information systems (CVIS) provide various advantage to health systems when successfully implemented. By comparing CPACS vs. CVIS, CPACS, similar to radiology PACS, mainly focuses on the storage and retrieval of cardiology-centric images. The growth of the global cardiovascular information system (CVIS) is driven by the factors such as the rising incidence of heart disease, increasing government initiatives towards the implementation of electronic health record systems,technological development, increasing demand for data-driven technologies is expected to propel the growth of this market. The global  cardiovascular information system (CVIS) market  is expected to have a market value of USD 1,560.93 million by 2027. Segment Analysis The global cardiovascular information system (CVIS) market is segmented into component, application, and end user. The component segment is further segment

  Market Insights The global cell therapy market is due to grow at a CAGR of 10.6% during the forecast period of 2017 to 2023 according to Market Research Future's latest report on the subject. Cell therapy market  has emerged as a transformative field in biotechnology due to its use for the targeting of various diseases at a cellular level. The above-average growth expected by this market will primarily be due to the rapidly advancing healthcare sector and growing breakthrough research and development activities. Cell therapy is finding a growing number of applications in healthcare and is often used in combination with gene therapy. Presently, applications of cell therapy include urinary problems, cancers, autoimmune disease, and infectious disease among several others. The growing prevalence of chronic and lifestyle diseases is an important driver for the cell therapy market.  cell therapy processing  is also being developed in regenerative medicine which carries massive potenti

  Market Highlights The global  drug discovery informatics market  held a market value of USD 1,680.6 million in 2017 and is projected to grow at a CAGR of 11.5% over the forecast period. Drug discovery and development is an extremely complex process requiring the generation of very large amounts of information data and. As the pharmaceutical and biotechnology industry is on the rise, information technology is supporting the drug discovery process to improve research productivity and success rates. Patent expiry of blockbuster drugs, an over-reliance on high throughput discovery strategies, and ongoing industry consolidation through mergers and acquisitions (M&A) are fueling the demand for drug discovery informatics. Few of the market growth factors include a worldwide rising focus on drug discovery, growing need to control drug discovery and development costs, rising research and development (R&D) expenditure, and increasing burden of chronic diseases. For instance, according

  Market Highlights The rising cases of sports-related injuries and technological advancements are some of the key factors driving the soft tissue repair market. For instance, in 2016, Colorado Therapeutics received FDA approval for its xenograft implant. The xenograft implant is designed for the surgical repair of damaged or ruptured membranes. The Global  Soft Tissue Repair Market  is expected to grow at an approximate CAGR of 6.2% during the forecast period, 2018–2023. Various other factors such as increasing awareness about orthopedic disorders and other related conditions, improvement in reimbursement policies, untapped emerging markets, and increasing healthcare expenditure are also expected to propel the growth of the market. However, the high cost of  advanced soft tissue release  equipment and a shortage of physicians in emerging markets can hamper market growth over the forecast period. Segmentation The global soft tissue repair market is segmented based on product, applicati